Doped carbon dots and uses thereof
US-2024016157-A1 · Jan 18, 2024 · US
US11700855B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11700855-B2 |
| Application number | US-202017093715-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 10, 2020 |
| Priority date | Sep 27, 2018 |
| Publication date | Jul 18, 2023 |
| Grant date | Jul 18, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of synthesizing Bi 2 S 3 —CdS particles in the form of spheres as well as properties of these Bi 2 S 3 —CdS particles are described. Methods of photocatalytic degradation of organic pollutants employing these Bi 2 S 3 —CdS particles and methods of preventing or reducing microbial growth on a surface by applying these Bi 2 S 3 —CdS particles in the form of a solution or an antimicrobial product onto the surface are also specified.
Opening claim text (preview).
The invention claimed is: 1. A method for reducing growth of a microorganism on a surface, the method comprising: applying Bi 2 S 3 —CdS particles onto the surface, wherein the Bi 2 S 3 —CdS particles comprise bismuth(III) sulfide and cadmium(II) sulfide, wherein the Bi 2 S 3 —CdS particles are in sphere form, wherein the Bi 2 S 3 —CdS particles are in contact with the surface for a time period in a range of from 1 to 24 hours, and wherein the microorganism is at least one gram-negative bacterium selected from the group consisting of Acinetobacter baumannii, Enterobacter aerogenes, Escherichia coli, Klebsiella oxytoca , and Klebsiella pneumoniae , or wherein the microorganism is at least one gram-positive bacterium selected from the group consisting of Staphylococcus aureus, Staphylococcus epidermis , and MRSA. 2. The method of claim 1 , wherein an atomic ratio of bismuth to cadmium in the Bi 2 S 3 —CdS particles is in a range of from 0.5:1 to 4:1, and an atomic ratio of sulfur to bismuth in the Bi 2 S 3 —CdS particles is in a range of from 3:2 to 8:1. 3. The method of claim 1 , Wherein the Bi 2 S 3 —CdS particles have a BET surface area in a range of from 5 to 25 m 2 /g, a pore size in a range of from 10 to 50 nm, and a pore volume in a range of from 0.02 to 0.2 cm 3 /g. 4. The method of claim 1 , herein the Bi 2 S 3 —CdS particles are applied onto the surface as a solution comprising a solvent, and relative to a total solution volume, the Bi 2 S 3 —CdS particles in a range of from 1 μg/mL to 50 mg/ml. 5. The method of claim 4 , wherein the solvent comprises dimethyl sulfoxide and water. 6. The method of claim 1 , wherein the microorganism is at least one gram-negative bacterium selected from the group consisting of Acinetobacter baumannii, Enterobacter aerogenes, Escherichia coli, Klebsiella oxytoca , and Klebsiella pneumoniae. 7. The method of claim 1 , wherein the microorganism is at least one gram-positive bacterium selected from the group consisting of Staphylococcus aureus, Staphylococcus epidermis , and MRSA. 8. The method of claim 1 , wherein the microorganism comprises the Acinetobacter baumannii. 9. The method of claim 1 , wherein the microorganism comprises the Enterobacter aerogenes. 10. The method of claim 1 , wherein the microorganism comprises the Escherichia coli. 11. The method of claim 1 , wherein the microorganism comprises the Klebsiella oxytoca. 12. The method of claim 1 , wherein the microorganism comprises the Klebsiella pneumoniae. 13. The method of claim 1 , wherein the microorganism comprises the Staphylococcus aureus. 14. The method of claim 1 , wherein the microorganism comprises the Staphylococcus epidermis. 15. The method of claim 1 , wherein the microorganism comprises the MRSA. 16. The method of claim 1 , wherein a count of the microorganism on the surface is reduced by at least 50%, relative to an untreated control surface. 17. The method of claim 1 , wherein a count of the microorganism on the surface is reduced by at least 70%, relative to an untreated control surface. 18. The method of claim 4 , wherein, relative to the total solution volume, the Bi 2 S 3 —CdS particles in a range of from 10 μg/mL to 100 μg/mL. 19. The method of claim 13 , wherein the Bi 2 S 3 —CdS particles are applied onto the surface as a solution comprising a solvent, and relative to a total solution volume, the Bi 2 S 3 —CdS particles in a range of to 100 μg/mL. 20. The method of claim 1 , consisting of the applying of the Bi 2 S 3 —CdS particles, optionally as a solution, onto the surface.
Related publications grouped by family.
Answers are generated from the same data shown on this page.